Abstract:Objective: There are no drugs to prevent the growth of abdominal aortic aneurysm (AAA), responsible for ~200,000 deaths in the world each year. There is a growing interest in natural anti-inflammatory compounds using nanotechnology-based drug-delivery. Mangiferin (MGF) is one such phytochemical isolated from Mangifera indica. Conjugation of MGF on gold nanoparticles (MGF-AuNPs) enhances bioavailability, through cellular penetration, presenting new opportunities toward the design of innovative nanomedicine agents. Recently, we have demonstrated the unique applications of MGF-AuNPs as an immunomodulatory therapeutic agent in the treatment of metastatic breast and prostate cancers. Here, we investigated whether MGF-AuNPs prevent the development of AAA. Approach and Results: Apoe –/– mice were subjected to angiotensin (AngII; 1μg/min/kg)-induced AAA. MGF-AuNPs (~7 mg/30g mouse) or starch (S)-AuNPs were administered daily, a week prior to AngII and continued for 28 days (n=6-12 per group). The incidences of AAA were significantly attenuated with MGF-AuNPs than AngII group (P<0.001), associated with a decrease in maximal intra-luminal diameter (P<0.001), pulse wave velocity (P<0.001), distensibility (P<0.05) and radial strain (P<0.05). Degradation of elastin (P<0.001), pro-inflammatory cytokines (P<0.01) and apoptotic cell death (P<0.01) were significantly reduced in the aortae of MGF-AuNPs treated Apoe –/– mice than AngII group. Mechanistically, Notch1, its ligands (Jag1, Dll4) and downstream targets (HeyL, NFκB2, pStat3), were significantly reduced by MGF-AuNPs in the aorta (P<0.01) than AngII group. In the macrophages overexpressed with activated Notch1 (NICD), MGF-AuNPs significantly diminished the expression of Jag1 (P<0.001), HeyL (P<0.001), Il6 (P<0.001) and NFκB2 (P<0.001). MGF-AuNPs also prevented the nuclear translocation of NICD and its downstream effector pStat3, in the macrophages transfected with NICD plasmid. Conclusion: Our studies provide compelling pre-clinical evidence of protective effects of MGF-AuNPs on AAA development through inactivation of Notch1 signaling, thus present realistic potential toward clinical translation of this nanoceutical for use as a non-invasive effective treatment for AAA.

Mercaptopyrimidine-templated gold nanoclusters for antithrombotic therapy

Synthesis and Antitumor Application of Antiangiogenetic Gold Nanoclusters

Design and characterization of antithrombotic ClEKnsTy-Au nanoparticles as diagnostic and therapeutic reagents

Sodium Ferulate-Functionalized Silver Nanopyramides with Synergistic Antithrombotic Activity for Thromboprophylaxis.

NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6C<SUP>low</SUP> Monocytes/Macrophages Differentiation to Accelerate Thrombolysis

Effect of Surface Chemistry Modification of Functional Gold Nanoparticles on the Drug Accumulation of Cancer Cells

The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.

Selective binding of cationic fibrinogen-mimicking chitosan nanoparticles to activated platelets and efficient drug release for antithrombotic therapy

A Peptide-Coated Gold Nanocluster Exhibits Unique Behavior in Protein Activity Inhibition.

Enhanced Antimicrobial Efficiency of Gold Nanoclusters via Improved Sonodynamic Activity and Out-Membrane Crossing Capacity

Abstract 300: Mangiferin Conjugated Gold Nanoparticles Protect Against The Development Of Abdominal Aortic Aneurysm In Apoe–/– Mouse Model

Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing l-Arg and l-Asp or l-Glu

Engineered endothelium-mimicking antithrombotic surfaces via combination of nitric oxide-generation with fibrinolysis strategies

Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy

An in Situ Grown Ultrathin and Robust Protein Nanocoating for Mitigating Thromboembolic Issues Associated with Cardiovascular Medical Devices.

Endothelium-Mimetic Surface Modification Improves Antithrombogenicity and Enhances Patency of Vascular Grafts in Rats and Pigs

Clot structure-based physical-matching design of platelet cloaking nano-delivery system facilitates specific arteriovenous thrombolysis

Physical‐Matched Nanoplatelets Boost Heterogeneous Thrombi Targeting Through Self‐Adaptive Deformation for Thrombolysis and Endothelial Repairing

Thrombotic microenvironment responsive crosslinking cyclodextrin metal-organic framework nanocarriers for precise targeting and thrombolysis

Synthesis of Ultrastable and Multifunctional Gold Nanoclusters with Enhanced Fluorescence and Potential Anticancer Drug Delivery Application

Mussel-Inspired and Bioclickable Peptide Engineered Surface to Combat Thrombosis and Infection